Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Yanina Jansen(Universitair Ziekenhuis Brussel), Elisa A. Rozeman(The Netherlands Cancer Institute), Robert M. Mason(Greenslopes Private Hospital), Simone M. Goldinger(University Hospital of Zurich), Marnix H. Geukes Foppen(The Netherlands Cancer Institute), Lise Hoejberg(Odense University Hospital), Henrik Schmidt(Aarhus University), Johannes V. van Thienen(The Netherlands Cancer Institute), John B.A.G. Haanen(The Netherlands Cancer Institute), Leena Tiainen(Tampere University Hospital), Inge Marie Svane(Herlev Hospital), Siru Mäkelä(University of Helsinki), Teofila Seremet(Universitair Ziekenhuis Brussel), Ana Arance(Hospital Clínic de Barcelona), Reinhard Dummer(University Hospital of Zurich), Lars Bastholt(Odense University Hospital), Marta Nyakas(Oslo University Hospital), Oddbjørn Straume(University of Bergen), Alexander M. Menzies(Mater Health Services), Georgina V. Long(Mater Health Services), Victoria Atkinson(Greenslopes Private Hospital), Christian U. Blank(The Netherlands Cancer Institute), Bart Neyns(Universitair Ziekenhuis Brussel)
Cited by 228Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis